{"transactions":[{"id":743084,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T10:04:27.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":36000,"price":37.7,"value":1357200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":284751,"source":{"system":"sec-edgar","filing":"0002014866-26-000011","document":"wk-form4_1781085864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000011/wk-form4_1781085864.xml","form_type":"4"}},{"id":837858,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:32:18.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":6302,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 14, 2024, the reporting person was granted 6,302 RSUs in accordance with the Indivior Group Deferred Bonus Plan 2018. Those RSUs vested in a single installment on March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 14, 2024, the reporting person was granted 6,302 RSUs in accordance with the Indivior Group Deferred Bonus Plan 2018. Those RSUs vested in a single installment on March 14, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-14","underlying":"Common Stock","underlying_shares":6302},"source":{"system":"sec-edgar","filing":"0002014866-26-000008","document":"wk-form4_1773779535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000008/wk-form4_1773779535.xml","form_type":"4"}},{"id":837857,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:32:18.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2843,"price":31.11,"value":88445.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares used to satisfy tax withholding obligations associated with the vesting of RSUs on March 14, 2026."}],"balance_after":320751,"source":{"system":"sec-edgar","filing":"0002014866-26-000008","document":"wk-form4_1773779535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000008/wk-form4_1773779535.xml","form_type":"4"}},{"id":837856,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:32:18.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":6302,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis."}],"balance_after":323594,"source":{"system":"sec-edgar","filing":"0002014866-26-000008","document":"wk-form4_1773779535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000008/wk-form4_1773779535.xml","form_type":"4"}},{"id":858300,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T21:00:14.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":113510,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2028-03-03","underlying":"Common Stock","underlying_shares":113510},"source":{"system":"sec-edgar","filing":"0002014866-26-000006","document":"wk-form4_1772744411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000006/wk-form4_1772744411.xml","form_type":"4"}},{"id":858299,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:14.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":86949,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":317292,"source":{"system":"sec-edgar","filing":"0002014866-26-000006","document":"wk-form4_1772744411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000006/wk-form4_1772744411.xml","form_type":"4"}},{"id":858298,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:14.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":87597,"price":31.98,"value":2801352.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In 2024, 204,904 shares vested in respect of performance stock units granted to the Reporting  Person on March 3, 2021.  These shares were subject to a further two-year holding period. On March 3, 2026, the holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations."}],"balance_after":230343,"source":{"system":"sec-edgar","filing":"0002014866-26-000006","document":"wk-form4_1772744411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000006/wk-form4_1772744411.xml","form_type":"4"}},{"id":907554,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:07:23.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":113510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person."}],"balance_after":113510,"derivative":{"exercise_price":0,"exercise_date":"2028-03-03","underlying":"Common Stock","underlying_shares":113510},"source":{"system":"sec-edgar","filing":"0002014866-26-000004","document":"wk-form4_1770930440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000004/wk-form4_1770930440.xml","form_type":"4"}},{"id":907553,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:07:23.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":37358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":317940,"source":{"system":"sec-edgar","filing":"0002014866-26-000004","document":"wk-form4_1770930440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000004/wk-form4_1770930440.xml","form_type":"4"}}]}